Back to products
Immunosuppressant
- All products
- Hepatitis B Virus28 products
Bladder Cancer39 products
Breast Cancer38 products
- Colorectal Cancer28 products
Diabetic25 products
- Endometrial Cancer29 products
- Hepatitis C Virus21 products
- Leukaemia3 products
- ONCOLOGY PRODUCTS29 products
- Rectal Cancer16 products
- Solid Tumor6 products
- Taskin50 products
- Anti-Diabetic6 products
- BEST SELLER16 products
- Bladder Cancer19 products
- Breast Cancer19 products
- Colon & Rectal Cancer12 products
- Colorectal Cancer10 products
- Diabetic12 products
- Endometrial Cancer13 products
- Hepatitis B Virus7 products
- Hepatitis C Virus9 products
- Ibrutinib4 products
- Kidney Cancer22 products
- Leukaemia12 products
- Liver Cancer22 products
- Lung Cancer24 products
- Lymphoma13 products
- Mantle Cell Lymphoma11 products
- Melanoma12 products
- Non-Hodgkin7 products
- ONCOLOGY18 products
- ONCOLOGY PRODUCTS41 products
- Tumor2 products
TOFACINIX 11 MG
Tofacinix Tablet (Extended Release) Tofacitinib 11 mg Beacon Pharmaceuticals Ltd. Indications Rheumatoid Arthritis: Tofacitinib is indicated for the treatment of adult
TOFANIB 5 MG
Tofanib Tablet Tofacitinib 5 mg Globe Pharmaceuticals Ltd. Indications Rheumatoid Arthritis: Tofacitinib is indicated for the treatment of adult patients with
TOFAXEN 5 MG
Tofaxen Tablet Tofacitinib 5 mg Everest Pharmaceuticals Ltd. Indications Rheumatoid Arthritis: Tofacitinib is indicated for the treatment of adult patients with
XEVIROL 5 MG
Xevirol Tablet Everolimus 5 mg Beacon Pharmaceuticals Ltd. Indications Everolimus is indicated in advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer (Advanced HR+
